W. McBlain

发表

Androgen receptor in the harderian glands of the golden hamster: characterization and the effects of androgen deprivation, the pituitary, and gender.

R. A. Hoffman, G. Buzzell, W. McBlain, 1994, The Journal of experimental zoology.

Acute intraperitoneal toxicity of DDT and PCB's in mice using two solvents

F. Wolfe, W. McBlain, V. Lewin, 1972, Bulletin of environmental contamination and toxicology.

Applicability of nuclear androgen receptor quantification to human prostatic adenocarcinoma.

D. Fentie, W. Lakey, W. McBlain, 1986, The Journal of urology.

Relationship between concentrations of extractable and matrix-bound nuclear androgen receptor and clinical response to endocrine therapy for prostatic adenocarcinoma.

W. Lakey, W. McBlain, S. E. Gonor, 1984, The Journal of urology.

Heparin-mediated inactivation and transformation of mammary cytoplasmic glucocorticoid receptor.

G. Shyamala, W. McBlain, 1984, Journal of steroid biochemistry.

Transformation of mammary cytoplasmic glucocorticoid receptor under cell-free conditions.

G. Shyamala, D. Toft, W. McBlain, 1981, Biochemistry.

Effects of Olfactory Bulbectomy, Melatonin, and/or Pinealectomy on Three Sublines of the Dunning R3327 Rat Prostatic Adenocarcinoma

J. G. Toma, H. Amerongen, G. Buzzell, 1987, Journal of pineal research.

Androgen binding sites on nuclear matrix of normal and hyperplastic human prostate.

W. Lakey, W. McBlain, B. J. Donnelly, 1984, The Journal of urology.

Limited accumulation of DDT in eggs, fat and livers of Japanese quail.

F. Wolfe, W. McBlain, V. Lewin, 1974, Poultry Science.

The levo enantiomer of o,p'-DDT inhibits the binding of 17 beta-estradiol to the estrogen receptor.

W. McBlain, 1987, Life sciences.

Inactivation of mammary cytoplasmic glucocorticoid receptors under cell-free conditions.

G. Shyamala, W. McBlain, William, 1980, The Journal of biological chemistry.

An empirical basis for the competition by dexamethasone to progesterone receptors as estimated with the synthetic progestin R5020.

S. Haslam, G. Shyamala, W. McBlain, 1981, Journal of receptor research.

Distinction between progestin- and glucocorticoid-binding sites in mammary glands. Apparent lack of cytoplasmic progesterone receptors in lactating mammary glands.

G. Shyamala, W. McBlain, 1979, The Biochemical journal.

Estrogen receptor in human benign prostatic hyperplasia.

B. Donnelly, W. Lakey, W. McBlain, 1983, The Journal of urology.

Resolution of the optical isomers of o,p′-DDT

F. Wolfe, W. McBlain, 1975 .

Estrogenic effects of the enantiomers of o,p′-DDT in Japanese quail

F. Wolfe, W. McBlain, V. Lewin, 1977 .

Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.

R. Fourney, A. Lees, D. Slamon, 1991, Cancer research.

Immunoassay for estrogen receptor does not detect inactivated receptor.

K. Tran, L. Molnar, W. A. McBlain, 1989, Clinical chemistry.

Differing estrogenic activities for the enantiomers of o, p'-DDT in immature female rats.

W. McBlain, V. Lewin, 1976, Canadian journal of physiology and pharmacology.

Facial route to the resolution of the enantiomers of 1-chloro-2-[2,2,2-trichloro-1-(4-chlorophenyl) Ethyl]benzene(o,p'-DDT.

R. Currie, F. Wolfe, W. McBlain, 1976, Journal of agricultural and food chemistry.